HIIFS
EW icon

Harel Insurance Investments & Financial Services’s Edwards Lifesciences EW Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
20,280
+3,634
+22% +$304K 0.01% 174
2026
Q1 		$1.33M Buy
16,646
+3,768
+29% +$311K 0.01% 157
2025
Q4 		$1.1M Buy
12,878
+2,176
+20% +$179K 0.01% 172
2025
Q3 		$832K Buy
10,702
+3,349
+46% +$262K 0.01% 202
2025
Q2 		$575K Buy
7,353
+1,859
+34% +$139K 0.01% 214
2025
Q1 		$398K Buy
5,494
+595
+12% +$42.6K 0.01% 227
2024
Q4 		$363K Sell
4,899
-917
-16% -$64.2K 0.01% 172
2024
Q3 		$384K Buy
5,816
+2,032
+54% +$148K 0.01% 180
2024
Q2 		$350K Buy
3,784
+792
+26% +$70.1K 0.01% 199
2024
Q1 		$286K Sell
2,992
-32
-1% -$2.69K 0.01% 216
2023
Q4 		$231K Sell
3,024
-538
-15% -$37.4K ﹤0.01% 271
2023
Q3 		$247K Buy
3,562
+1,510
+74% +$121K ﹤0.01% 273
2023
Q2 		$194K Buy
2,052
+1,622
+377% +$141K ﹤0.01% 315
2023
Q1 		$35K Hold
430
– – ﹤0.01% 534
2022
Q4 		$32K Hold
430
– – ﹤0.01% 538
2022
Q3 		$36K Hold
430
– – ﹤0.01% 541
2022
Q2 		$41K Hold
430
– – ﹤0.01% 536
2022
Q1 		$51K Sell
430
-14,620
-97% -$1.64M ﹤0.01% 510
2021
Q4 		$1.96M Buy
15,050
+14,500
+2,636% +$1.69M 0.04% 122
2021
Q3 		$62K Sell
550
-1,388
-72% -$158K ﹤0.01% 511
2021
Q2 		$654K Sell
1,938
-682
-26% -$64.3K 0.01% 400
2021
Q1 		$732K Buy
2,620
+222
+9% +$18.8K 0.01% 430
2020
Q4 		$704K Buy
2,398
+550
+30% +$45.6K 0.02% 317
2020
Q3 		$148K Buy
1,848
+1,400
+313% +$109K 0.01% 344
2020
Q2 		$31K Buy
+448
New +$31.8K ﹤0.01% 430

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Harel Insurance Investments & Financial Services's EW Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services increased its Edwards Lifesciences (EW) stake by 22% in Q2 2026, buying an estimated $304K and bringing the position to 20,280 shares worth $1.83M. The position accounts for 0.01% of the portfolio, ranked #174.

Harel Insurance Investments & Financial Services first reported a position in EW in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.96M in Q4 2021. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 20,280 shares of Edwards Lifesciences worth $1.83M as of Q2 2026.
  • Harel Insurance Investments & Financial Services bought 3,634 Edwards Lifesciences shares in Q2 2026, an estimated $304K.
  • Edwards Lifesciences made up 0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #174 holding.
  • Harel Insurance Investments & Financial Services first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 25 quarters since.
  • Harel Insurance Investments & Financial Services's Edwards Lifesciences position peaked at $1.96M in Q4 2021.
  • 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.